|
Patient | Age/Sex | Diagnosis | Surgical procedure | Neoadjuvant chemotherapy | Pathology (TNM) | Category |
|
A | 49/M | Ductal adenocarcinoma pancreatic body | Distal pancreatectomy, splenectomy, celiac trunk resection, portal vein wedge resection | No | pT2 pN1 (2/24) L1 V1 Pn1 G3 | R1 |
|
B | 66/M | Ductal adenocarcinoma pancreatic head | PPPD, portal vein wedge resection | No | pT2 pN1 (3/21) L1 V0 Pn1 G2 | R1 |
|
C | 82/M | IPMC | PPPD, portal vein wedge resection | No | pT1c pN0 (0/28) L0 V0 Pn0 G2 | R0 |
|
D | 63/M | Ductal adenocarcinoma pancreatic body | Distal pancreatectomy, splenectomy, celiac trunk resection, portal vein wedge resection | No | pT2 pN0 (0/11) L0 V1 Pn1 G2 | R1 |
|
E | 58/F | Ductal adenocarcinoma pancreatic tail | Distal pancreatectomy, splenectomy, Portal vein segment resection | Yes FOLFIRINOX (6#) | ypT2 ypN0 (0/11) L0 V1 Pn1 G2 | R1 |
|
F | 65/F | Ductal adenocarcinoma pancreatic body | Distal pancreatectomy, splenectomy, Portal vein wedge resection | No | pT2 pN2 (5/48) L0 V1 Pn1 G3 | R1 |
|
G | 70/M | Ductal adenocarcinoma pancreatic head | Pylorus preservation pancreatectomy, portal vein wedge resection | Yes FOLFIRINOX (10#) | ypT2 ypN2 (4/24) L0 V0 Pn0 G2 | R0 |
|
H | 63/F | Ductal adenocarcinoma pancreatic head | Pylorus preservation pancreatectomy, portal vein wedge resection | Yes FOLFIRINOX (6#) | ypT3 ypN1 (1/17) L0 V0 Pn1 G2 | R1 |
|
I | 72/F | Ductal adenocarcinoma pancreatic head | PPPD, portal vein wedge resection | No | pT3 pN1(1/12) L0 V1 Pn1 G2 | R1 |
|
J | 43/F | Ductal adenocarcinoma pancreatic head | PPPD, portal vein segment resection | No | pT2 pN0 (0/14) L0 V0 Pn1 G2 | R0 |
|
K | 63/M | Ductal adenocarcinoma pancreatic head | PPPD, portal vein wedge resection | No | pT3 N0 (0/28) R0 L0 V0 Pn1 G3 | R0 |
|